$EPGL - MAJOR TWITTER UPDATE Just out - Huge details MUST

New Post Public Reply Private Reply Replies (0) Message Board
Vikingzskillz
$EPGL - MAJOR TWITTER UPDATE Just out - Huge details MUST READ! $COO #IoT #bioniclens

CooperVision approached EPGL in 2013 and asked for Exclusive to a particular technology. In 2014 CooperVision approache'd EPGL again to secure exclusive rights to EPGL's advanced ophthalmic enabling technology and all other EPGL medical device technology. In April 2014 CooperVision then asked EPGL to jointly develop certain key technologies which it represented to EPGL to be several billion dollars in annual sales in the ophthalmic space. CooperVision and EPGL subsequently invented multiple key technologies for electronics in contact lenses, which the two companies jointly own, but CooperVision must secure licensing rights via mutually acceptable terms for licensing fees.

In January 2015, CooperVision again approached EPGL to ask for early granting of the licensing Option by 9 months . EPGL rejected that request. In March of 2015, CooperVision demanded EPGL enter mediation as a venue for EPGL to be presented with new offers from CooperVision. EPGL initially rejected the request for mediation as it thought it would not be effective. EPGL reluctantly agreed to CooperVision's suggestion of mediation and the two companies teams met on May 18th 2015 in San Francisco, California. EPGL again rejected CooperVision's offer.

This is where it stands now. CooperVision continues to pursue rights to commercialization of these groundbreaking ophthalmic technologies, but terms have not been agreed to yet as the Agreement requires. EPGL will continue to consider settlement, but to be clear, these technologies have the potential to revolutionize vision, so EPGL will not allow use of it in the market unless EPGL has potential to earn substantial royalties over time.

The coming industry of vision augmentation and and bionic vision enhancements, is mind boggling over the coming years and decades. It could potentially be the next big revolution in integration of communication technology into the human body. Nothing like less than the next coming of the Internet, wired into human vision. EPGL has filed patent on novel new display technology directly into the retina of the eye. EPGL has intimate knowledge of the contact lens manufacturing process via CooperVision and we solved some key hurdles to electronics integration within contact lenses.

Want to have eyes like a teenager for life? Want to have "zoom" vision or microscopic vision? Want to be able to see text and images in your vision? How about being able to literally see everything that your smartphone can display, directly in your vision at will?

These are the capabilities that EPGL and CooperVision have been working on for nearly two years now. Google, Apple, Microsoft and many others may have to pay EPGL and/or CooperVision royalties everytime a smartphone displays into the eyes in the future. Do people realize what this coming revolution will mean to the world? It has potential to rival the computer PC, Internet and Smartphone revolutions combined.

Arguably, there is nothing more important than vision to human beings. Facebook is spending billions in the space, as has Google and Microsoft. Apple is also "eyeing" the space. The good news for EPGL shareholders is that you own some of the most potentially valuable technology in this revolution that there is.

It is not a fantasy of some penny stock company. It is reality. We own some of the most brilliant new technology in wearable vision enhancements. If only one of our several new joint patents is granted it could be the gateway technology for hundreds of vision applications. But EPGL has several, not just one. We will come to terms soon either out of court or within it, but make no mistake, there's a lot at stake here and both EPGL and CooperVision know it. We're not going to give it away. Our long shareholders have already seen major gains at EPGL. Could we just be getting started? We believe YES."
Scroll down for more posts ▼

Top 10 Most Recent News Articles

Copper Peptides Shine in New Renue Blue Cream

Updated Category News Views 171

Renue By Science's Ambitious Skincare Launch Alright, we've got a big player stepping up in the realm of skincare with a new face cream packed tightly with science-backed goodies. Renue By Science is revamping their game by anchoring their new Renue Blue Face Cream around the star of the moment: copper tripeptide-1, also known as GHK-Cu. This is more than a beauty gloss...

Continue Reading
Alley Cat Allies Pushes for Humane Cat Conservation Bill

Updated Category News Views 70

Time to Rethink Conservation: Save the Cats If you’re tuned into the chatter buzzing around the Cayman Islands, you know the clocks are ticking for a decision that could change the approach to handling community cats. Alley Cat Allies is waving the flag, urging the Cayman Islands Parliament to pass a bill that abandons the archaic practice of culling cats by shooting...

Continue Reading
Cognito Unveils Phase 3 Results for Alzheimer Treatment

Updated Category News Views 292

Charting New Waters in Alzheimer's Treatment Well, here's one for the books, folks. Cognito Therapeutics just tossed their latest Phase 3 results from their so-called HOPE study into the ring. We're talking about Spectris AD, a non-drug, at-home gizmo that aims to be the next big thing for Alzheimer's. Yeah, the study didn't exactly hit a home run with the primary...

Continue Reading
Endava's Audit Scandal: Investors Face Crucial Decision

Updated Category News Views 156

Endava's Unexpected Crisis: What's Happening? It's the kind of mess no investor wants to wake up to: on October 28, 2026, Endava plc (NYSE: DAVA) laid out a smorgasbord of screw-ups that have left the market reeling. The company's last few days were a whirlwind, featuring the CFO's abrupt exit and the CEO swap. This shake-up didn't happen in isolation—the announcement...

Continue Reading
Peptide Tracker Refresh Unveils New Planning Features

Updated Category News Views 136

Peptide Tracker's Latest Updates: A Game Changer? I'll tell you what—if you're keeping tabs on your peptide intake like a seasoned gardener checks the soil, Peptide Tracker's fresh versions 3.2.0 and 3.3.0 might just be your new best mates. With the addition of washout scheduling and a robust six-month schedule preview, this isn't just another fancy tech update. It's...

Continue Reading
Kos & FORTH Partner to Spark Greek Biotech Growth

Updated Category News Views 81

New Frontiers: Greece on the Biotech Map Partnerships in biotech aren't tossed out willy-nilly; they're crafted for precision much like a sculptor shaping marble. Kos Biotechnology Partners and the Foundation for Research and Technology-Hellas (FORTH) are doing exactly that, teaming up to birth a biotechnology incubator on the FORTH campus in Heraklion, Crete. Now tell...

Continue Reading
Local Bounti Expands: Acquires CEA Facilities

Updated Category News Views 72

Local Bounti's Strategic Acquisition Move Local Bounti's at it again, shaking up the indoor agriculture scene by snapping up some real estate from Revol Greens. We're talking 30 acres of primo certified-organic greenhouse space across Texas and Minnesota. And they’re picking these babies up right as they’re ready to grow, not like some flashy land grab. Digging into...

Continue Reading
Quantum X and Everest Cloud Partner in South Asia Push

Updated Category News Views 108

An Unlikely Alliance for Cutting-Edge Tech You gotta admit, the fusion of a U.S.-based tech outfit with a Nepalese cloud provider wasn't the market move anyone saw coming. But here we are—Quantum X is hitching its quantum computing dreams to Everest Cloud's solid local foothold across six South Asian markets. We're talking Nepal, India, Bangladesh, Bhutan, Sri Lanka,...

Continue Reading
BWIN Acquisition Under Scrutiny: Shareholders Alerted

Updated Category News Views 118

BWIN Shareholders in the Hot Seat Over Acquisition Ever feel like you're the last one to know when the music stops in this investing dance? Well, if you're holding shares of The Baldwin Insurance Group, Inc. (NASDAQ:BWIN), it's time to put down your coffee and tune in. Levi & Korsinsky, LLP threw a wrench in the works, launching an investigation to see if this Sequence...

Continue Reading
Apotex Enters U.S. Market with Axitinib Tablets Launch

Updated Category News Views 114

Apotex's Bold Move: Axitinib Tablets Hit the U.S. Market Apotex is shaking things up in the pharma world by launching the first generic version of Axitinib Tablets in the U.S., aimed at treating advanced renal cell carcinoma (RCC) when previous treatments have fallen flat. This isn't just another dance with the red tape—it's a major step for Apotex, flexing their muscle...

Continue Reading

Top 5 Most Recently Viewed Articles

Exploring Natural Hydrogen: MAX Power Mining's Vision

Updated Category News Views 184

MAX Power Mining Corp. Driving Innovation in Natural Hydrogen In an era where energy demands are escalating, especially with the rise of artificial intelligence and advanced technologies, the search for sustainable power sources has reached new heights. Enter MAX Power Mining Corp. (OTC: MAXXF) (CSE: MAXX), a trailblazer in the natural hydrogen sector, demonstrating...

Continue Reading
Inland Empire Health Plan Achieves Excellence in GIS Recognition

Updated Category News Views 246

A Celebration of Achievement for Inland Empire Health Plan Inland Empire Health Plan (IEHP) has achieved remarkable recognition by winning its third Special Achievement in GIS (SAG) award from Esri, the global leader in Geographic Information System (GIS) technology. This prestigious accolade highlights IEHP's commitment to utilizing innovative technology to enhance...

Continue Reading
Ryp Labs Triumphs in Lineage’s Global Food Innovation Challenge

Updated Category News Views 226

Ryp Labs Triumphs in Lineage’s Global Food Innovation Challenge In a groundbreaking moment for sustainable food technology, Ryp Labs was announced as the standout winner of Lineage's prestigious innovation challenge aimed at transforming the global food supply chain. The challenge focused on innovative solutions that address pressing issues such as food waste and supply...

Continue Reading
Future Landscape of the UV Stabilizers Market by 2032

Updated Category News Views 176

Growth of the UV Stabilizers Market The UV stabilizers market is gaining momentum, projected to expand from USD 1.4 billion to USD 2.3 billion by 2032, with a compound annual growth rate (CAGR) of 5.5% during the 2024-2032 period. This growth is fueled by the increasing demand for materials that are durable and can endure the degrading effects of ultraviolet (UV)...

Continue Reading
Dr. Rushika Fernandopulle Joins Premera Board of Directors

Updated Category News Views 337

Dr. Rushika Fernandopulle Joins Premera's Board Premera Blue Cross is excited to announce the addition of Dr. Rushika Fernandopulle to its Board of Directors. This decision is part of a strategic effort to strengthen leadership and expertise within the organization. Dr. Fernandopulle takes over from Dr. John Jenrette, who has completed his term this year. Expertise and...

Continue Reading